8.65
전일 마감가:
$6.81
열려 있는:
$7.15
하루 거래량:
669.36K
Relative Volume:
8.71
시가총액:
$138.57M
수익:
-
순이익/손실:
$-14.72M
주가수익비율:
-3.0565
EPS:
-2.83
순현금흐름:
$-7.41M
1주 성능:
+16.42%
1개월 성능:
+103.53%
6개월 성능:
+61.09%
1년 성능:
+0.00%
Alpha Cognition Inc Stock (ACOG) Company Profile
명칭
Alpha Cognition Inc
전화
(858) 344-4375
주소
1200-750 W PENDER ST, VANCOUVER
ACOG을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
ACOG
Alpha Cognition Inc
|
8.65 | 119.03M | 0 | -14.72M | -7.41M | -2.83 |
![]()
ONC
Beigene Ltd Adr
|
228.38 | 25.07B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
438.65 | 109.14B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 36.39M | 0 | 0 | 0 | 0.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
594.32 | 56.98B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
VRNA
Verona Pharma Plc Adr
|
71.31 | 5.39B | 0 | -153.72M | -103.81M | -2.00 |
Alpha Cognition Inc Stock (ACOG) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-03-18 | 개시 | H.C. Wainwright | Buy |
Alpha Cognition Inc 주식(ACOG)의 최신 뉴스
We Think Alpha Cognition (NASDAQ:ACOG) Can Easily Afford To Drive Business Growth - Yahoo Finance
Alpha Cognition Inc. Reports Strong Q1 2025 Performance - TipRanks
Alpha Cognition’s Earnings Call Highlights Success and Growth - TipRanks
Alpha Cognition Inc. (ACOG) Reports Q1 Loss, Misses Revenue Estimates - Nasdaq
Alpha Cognition Q1 2025 Earnings Call Transcript - MarketBeat
ALPHA COGNITION Earnings Results: $ACOG Reports Quarterly Earnings - Nasdaq
Alpha Cognition Inc. SEC 10-Q Report - TradingView
Alpha Cognition Inc. Reports First Quarter 2025 Financial Results and Operating Overview - BioSpace
Alpha Cognition (ACOG) Expected to Announce Earnings on Tuesday - Defense World
Alpha Cognition, Inc.’s (NASDAQ:ACOG) Lock-Up Period To Expire on May 12th - Defense World
Will Alpha Cognition's Recently Launched Alzheimer's Drug Be A Commercial Success? - RTTNews
Alpha Cognition to Report First Quarter 2025 Financial Results and Operating Overview - BioSpace
Alpha Cognition, Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference - The Kingston Whig Standard
Alpha Cognition to Present ZUNVEYL® (Benzgalantamine) Clinical Data at 2025 Alzheimer’s Association International Conference - Yahoo Finance
(Benzgalantamine) Clinical Data at 2025 Alzheimer’s Association International Conference - Business Wire
Alpha Cognition Inc. Reports Strong 2024 Financials - TipRanks
Alpha Cognition Strengthens Its Leadership Team with Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John Havens - BioSpace
Alpha Cognition announces board changes - Investing.com
Alpha Cognition announces board changes By Investing.com - Investing.com Canada
Alpha Cognition Appoints Robert Wills To Board - citybiz
Alpha Cognition Earnings Call: Positive Outlook Amid Growth - TipRanks
Alpha Cognition Announces a $44 Million Exclusive Licensing Agreement for the Development and Commercialization of ZUNVEYL (benzgalantamine), an FDA-Approved Treatment for Mild-to-Moderate Alzheimer’s Disease, in China - The Globe and Mail
Alpha Cognition stock hits 52-week low at $4.65 amid downturn - Investing.com Canada
HC Wainwright Expects Stronger Earnings for Alpha Cognition - Defense World
Stonegate Capital Partners Updates Coverage on Alpha Cognition Inc. (ACOG) Q4 2024 - TradingView
Alpha Cognition (NASDAQ:ACOG) Given Buy Rating at HC Wainwright - Defense World
Alpha Cognition Inc. (ACOG) reports earnings - Quartz
Alpha Cognition Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Operating Overview - Business Wire
Earnings Scheduled For March 31, 2025 - Benzinga
Comparing Alpha Cognition (ACOG) and The Competition - Defense World
Alpha Cognition (NASDAQ:ACOG) Upgraded at Raymond James - Defense World
Contrasting Alpha Cognition (NASDAQ:ACOG) & Cognition Therapeutics (NASDAQ:CGTX) - Defense World
Alpha Cognition (ACOG) Projected to Release Quarterly Earnings on Wednesday - Defense World
HC Wainwright Predicts Alpha Cognition Q1 Earnings - MarketBeat
Rosalind Advisors Inc. Invests $1.49 Million in Alpha Cognition, Inc. (NASDAQ:ACOG) - MarketBeat
Alpha Cognition (NASDAQ:ACOG) Now Covered by HC Wainwright - MarketBeat
Alpha Cognition Announces Positive Interim Pre-Clinical Data for ALPHA-1062 Use in a Military Relevant Model of Repetitive Mild Traumatic Brain Injury - The Globe and Mail
Alpha Cognition to Report Fourth Quarter and Full Year 2024 Financial Results and Operating Overview - Business Wire
90% Workforce Reduction Sent This Small Cap Soaring - The Globe and Mail
Alpha Cognition Inc (ACOG) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Alpha Cognition Inc 주식 (ACOG) 내부자 거래
내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
---|---|---|---|---|---|---|---|
MERTZ LEONARD POWELL | Director |
Nov 13 '24 |
Buy |
5.75 |
8,695 |
49,996 |
93,725 |
HAVENS JOHN PRENTISS | Director |
Nov 13 '24 |
Buy |
5.75 |
4,347 |
24,995 |
273,272 |
자본화:
|
볼륨(24시간):